NEXENTIS TECHNOLOGIES INC. Debt Instrument, Interest Rate, Stated Percentage
NEXENTIS TECHNOLOGIES INC. (NXTS) had Debt Instrument, Interest Rate, Stated Percentage of 16.80% as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2025-11-13
- 2025-06-30: Debt Instrument, Interest Rate, Stated Percentage 16.80%.
- 2025-05-12: Debt Instrument, Interest Rate, Stated Percentage 18.00%.
- 2025-03-31: Debt Instrument, Interest Rate, Stated Percentage 15.20%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2025-06-30 | 16.80% 10-Q · filed 2025-08-14 |
| 2025-05-12 | 18.00% 10-Q · filed 2025-11-13 |
| 2025-03-31 | 15.20% 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |